WithdrawnNot applicableNCT03352635

Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking Clinical and Biomarkers Core

The purpose of the study is to collect human biological samples and measurements from people of various ethnic and racial backgrounds for projects related to the "Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking" Program Project Grant. These samples will be used to evaluate and compare biomarkers of tobacco exposure across Japanese Americans, Whites, and Native Hawaiians and to add to the Multiethnic Cohort (MEC) biorepository to develop or assess future biomarkers.

Checked against the public recordLast updated Nov 24, 2017 · Source: ClinicalTrials.gov

StatusWithdrawn
PhaseNot applicable
U.S. locations2
SponsorUniversity of Minnesota
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Minnesota
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: 1. One of the three targeted ethnic groups: 1)Japanese American - two parents of Japanese descent; 2) Non-Hispanic Whites - two parents of non-Hispanic white descent; 3) Native Hawaiians will include individuals with at least one parent of Hawaiian descent; 2. Smoke 5 cigarettes per day over the past three months; 3. \>21 years of age; 4. Consumes 14 or fewer drinks of alcohol per week; 5. Generally stable and good health (determined by review of medical history); 6. Able to provide written voluntary consent before performance of any study related procedure. Exclusion Criteria: 1. Current use of other nicotine containing products for \> 4 times per month (and no use of any nicotine-containing products except cigarettes for 2 weeks prior to their study visits); 2. Acute or uncontrolled medical or psychiatric conditions; 3. Currently taking any medications that affect relevant metabolic enzymes or anti- inflammatory medications such as ibuprofen (this will be reviewed by study investigators on a case-by-case basis); 4. Active infection (e.g., influenza, cold, respiratory infection, sinus infection) at the time of the visit; 5. Pregnant or nursing or planning on becoming pregnant during the study; 6. Unable to read and understand English.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Tobacco Research Programs University of MinnesotaMinneapolis, Minnesota
  • Masonic Cancer Center, University of MinnesotaMinneapolis, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 24, 2017. Always confirm current availability with the study team.

View original record ↗